Publications



IRRADIATION-INDUCED UP-REGULATION OF HLA-E ON MACROVASCULAR ENDOTHELIAL CELLS CONFERS PROTECTION AGAINST KILLING BY ACTIVATED NATURAL KILLER CELLS


Isabelle Riederer, Wolfgang Sievert, Günther Eissner, Michael Molls, Gabriele Multhoff. (16-12-2010).

PLoS One., 2010, 5, (12):e15339

TNF-A RESPECIFIES HUMAN MESENCHYMAL STEM CELLS TO A NEURAL FATE AND PROMOTES MIGRATION TOWARD EXPERIMENTAL GLIOMA


V Egea, L von Baumgarten, C Schichor, B Berninger, T Popp, P Neth, R Goldbrunner, Y Kienast, F Winkler, M Jochum and C Ries. (03-12-2010).

Cell Death and Differentiation advance online publication, 2010

ALDEHYDE DEHYDROGENASE 1 POSITIVE GLIOBLASTOMA CELLS SHOW BRAIN TUMOR STEM CELL CAPACITY


Michael Rasper, Andrea Schäfer, Guido Piontek, Julian Teufel, Gero Brockhoff, Florian Ringel, Stefan Heindl, Claus Zimmer and Jürgen Schlegel. (13-07-2010).

Neuro Oncol., 2010

CLASSIFIATION OF HER2/NEU STATUS IN GASTRIC CANCER USING A BREAST-CANCER DERIVED PROTEOME CLASSFIER


Benjamin Balluff, Mareike Elsner, Andreas Kowarsch, Sandra Rauser, Stephan Meding, Christoph Schuhmacher, Marcus Feith, Ken Herrmann, Christoph Röcken, Roland M. Schmid, Heinz Höfler, Axel Walch and Matthias P. Ebert. (08-06-2010).

Journal of Proteome Research, 2010

IN VIVO IMAGING OF CT26 MOUSE TUMORS BY USING CMHSP70.1 MONOCLONAL ANTIBODY


Stefan Stangl, Mathias Gehrmann, Ralf Dressel, Frauke Alves, Christian Dullin, George Themelis, Vasilis Ntziachristos, Eva Staeblein, Axel Walch, Isabel Winkelmann, Gabriele Multhoff. (15-03-2010).

Journal of Cellular and Molecular Medicine - Decision on Manuscript ID JCMM, 2010

PERFORMANCE OF EPIGENETIC MARKERS SEPT9 AND ALX4 IN PLASMA FOR DETECTION OF COLORECTAL PRECANCEROUS LESIONS


Marc Tänzer, Benjamin Balluff, Jürgen Distler, Kari Hale, Andreas Leodolter, Christoph Röcken, Bela Molnar, Roland Schmid, Catherine Lofton-Day, Tibor Schuster, Matthias P. A. Ebert. (05-02-2010).

PLoS One, 2010, 5, 2

EFEMP1 AND P27 KIP1 MODULATE RESPONSIVENESS OF PANCREATIC CANCER CELLS TOWARDS A DUAL PI3K/MTOR INHIBITOR IN PRECLINICAL MODELS


Sandra Diersch, Patrick Wenzel, Melanie Szameitat, Philipp Eser, Mariel C. Paul, Barbara Seidler, Stefan Eser, Marlena Messer, Maximilian Reichert, Philipp Pagel, Irene Esposito, Roland M. Schmid, Dieter Saur, Günter Schneider. (26-02-2013).

Impact Journals, 2013, Vol. 4, No 2, 277-288

[18F]FLT IS SUPERIOR TO [18F]FDG FOR PREDICTING EARLY RESPONSE TO ANTIPORLIFERATIVE TREATMENT IN HIGH-GRADE LYMPHOMA IN A DOSE-DEPENDENT MANNER


Nicolas Graf, Ken Herrmann, Barbara Numberger, Daniela Zwisler, Michaela Aichler, Annette Feuchtinger, Tibor Schuster, Hans-Jürgen Wester, Reingard Senekowitsch-Schmidtke, Christian Peschel, Markus Schwaiger, Ulrich Keller, Tobias Dechow, Andreas K. Buck. (05-10-2012).

Springer Link, 2012, 40:34–43, Eur J Nucl Med Mol Imaging

FLT-PET IS SUPERIOR TO FDG-PET FOR VERY EARLY RESPONSE PREDICTION IN NPM-ALK-POSITIVE LYMPHOMA TREATED WITH TARGETED THERAPY


Li Z, Graf NA, Herrmann K, Jünger A, Aichler M, Feuchtinger A, Baumgart A, Walch A, Peschel C, Schwaiger M, Buck A, Keller U, Dechow T. (08-08-2012).

Cancer Res, 2012

DISCLOSURE OF ERLOTINIB AS A MULTIKINASE INHIBITOR IN PANCREATIC DUCTAL ADENOCARCINOMA


Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S, Michalski CW, Kleeff J, Schnieke A, Schmid RM, Saur D, Schneider G. (01-11-2011).

Neoplasia., 2011, 13(11), 1026-34